SL BIO focuses on innovation and breakthroughs, with a strong commitment to cancer treatment research

Date: October 10, 2024

William Wang started from the ground up, founding multiple companies focused on the development and innovation of semiconductor testing equipment. With over a decade of experience in the DRAM industry, his companies adopted a mindset of precision technology. SL BIO, with its rich background in semiconductor development, has now shifted its focus to cancer research and development. The company holds numerous patents, and its products are known for their efficiency, stability, and innovation. Key partners include research teams from Taipei Medical University, Hexun Biosciences, and CytoArm.

He has delved deeply into medical knowledge, guided and nurtured Taiwan’s biotech and medical teams, and led efforts to develop multiple advanced cell therapy techniques, all with the goal of reducing cancer treatment costs and side effects. William Wang firmly believes that "continuous learning, innovative breakthroughs, selfless dedication, and collaborative sharing" are the keys to success. He believes that only through continuous learning can one stay at the forefront of technology; only through innovation and breakthroughs can we solve challenges; only through selfless dedication can we truly help others; and only through cooperation can we achieve shared progress.

According to Taiwan's Ministry of Health and Welfare, cancer is the leading cause of death in the country. There are many people, due to cancer, having had to abandon promising careers, fulfilling lives, and their families. SL BIO Chairman William Wang has profound personal insight on the matter, as his father’s rapid decline from pancreatic cancer, diagnosed only months before his passing, left him unprepared and deeply affected. As a family member who experienced this sudden loss, Wang made a bold commitment to achieving a world free of cancer—a vision that goes beyond a mere slogan. Driven by this dream, he made a decisive shift from the semiconductor industry to the biotech field, focusing on cancer treatment research. He aims to apply the development and testing standards from his past work to biotech R&D, with the goal of turning this vision into a tangible, achievable "ideal."

In the fast-paced transitions between the semiconductor and biotech fields, William Wang has consistently adhered to two core principles—innovation and breakthroughs. He believes that the integration of technologies and cross-disciplinary applications are key to solving modern medical challenges. In the semiconductor field, he focused on precision and efficiency; in the biotech field, he carries forward the same spirit of innovation while emphasizing effective treatments. He is convinced that only through continuous technological progress and innovation can we truly benefit humanity and achieve the goal of making cancer controllable, or even curable.

The cell therapy technology he is dedicated to developing aims to replace traditional chemotherapy, reducing its side effects and improving patients' quality of life. Through technological innovation, he hopes to lower the costs of cancer treatment, making advanced therapies more accessible to a wider range of people. His ultimate goal is to increase the accessibility and effectiveness of cancer treatments, dispelling the notion that cancer is synonymous with death.